Histopathological evaluation of apoptosis in cancer

American Journal of Pathology

Volumn 153, Issue 4, 1998, Pages 1041-1053

  Soini, Y ^a   Paakko, P ^a   Lehto, V P ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYSTEINE PROTEINASE; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ADRENAL TUMOR; APOPTOSIS; BREAST CARCINOMA; CAENORHABDITIS ELEGANS; ENDOMETRIUM CARCINOMA; GASTROINTESTINAL CARCINOMA; HUMAN; LUNG CARCINOMA; LYMPHOMA; NONHUMAN; ONCOGENE; PRECANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; SOLID TUMOR; THYROID TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0031691804     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65649-0     Document Type: Review

References (171)

1. JFR Kerr AH Wyllie AR Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
2. G Majno I Joris Apoptosis, oncosis, and necrosis: an overview of cell death Am J Pathol 146 1995 3 15
3. MC Cummings CM Winterford NI Walker Apoptosis Am J Surg Pathol 21 1997 88 101
4. JFR Kerr CM Winterford BV Harmon Apoptosis: its significance in cancer and cancer therapy Cancer 73 1994 2013 2026
5. E White Life, death, and the pursuit of apoptosis Gene Dev 10 1996 1 15
6. E Yang SJ Korsmeyer Molecular thanatopsis: a discourse on the BCL2 family and cell death Blood 88 1996 386 401
7. SA Susin N Zamzami M Castedo E Daugas H-G Wang S Geley F Fassy JC Reed G Kroemer The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis J Exp Med 186 1997 25 37
8. M Leist P Nicotera The shape of cell death (breakthroughs and views) Biochem Biophys Res Commun 236 1997 1 9
9. MO Hengartner HR Horvitz Programmed cell death in Caenorhabditis elegans Curr Opin Genet Dev 4 1994 581 586
10. HR Horvitz S Shaham MO Hengartner The genetics of programmed cell death in the nematode Caenorhabditis elegans Cold Spring Harbor Symp Quant Biol 59 1994 377 385
11. MD Jacobson Apoptosis: Bcl-2 related proteins get connected Curr Biol 7 1997 R277 R281
12. DL Vaux CED-4: the third horseman of apoptosis Cell 90 1997 389 390
13. H Zou WJ Henzel X Liu A Lutschg X Wang Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3 Cell 90 1997 405 413
14. CB Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
15. S Cory Regulation of lymphocyte survival by the bcl-2 gene family Annu Rev Immunol 13 1995 513 543
16. M Colombel CA Olsson P-Y Ng R Buttyan Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle Cancer Res 52 1992 4313 4319
17. JW Wilson AE Wakeling ID Morris JA Hickman C Dive MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage Int J Cancer 61 1995 502 508
18. G Berke The CTL's kiss of death Cell 81 1995 9 12
19. T Miyashita JC Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
20. GS Wu TF Burns ER McDonald III W Jiang R Meng ID Krantz G Kao D-D Gan J-Y Zhou R Muschel SR Hamilton NB Spinner S Markowitz G Wu WS El-Deiry KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene Nat Genet 17 1997 141 143
21. JL Kummer PK Rao KA Heidenreich Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase J Biol Chem 272 1997 20490 20494
22. A Haimovitz-Friedman C-C Kan D Ehleiter RS Persaud M McLoughlin Z Fuks RN Kolesnick Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis J Exp Med 180 1994 525 535
23. YA Hannun The sphingomyelin cycle and the second messenger function of ceramide J Biol Chem 269 1994 3125 3128
24. YA Hannun Functions of ceramide in coordinating cellular responses to stress Science 274 1996 1855 1859
25. P Santana LA Peña A Haimovitz-Friedman S Martin D Green M McLoughlin C Cordon-Cardo EH Schuchman Z Fuks R Kolesnick Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis Cell 86 1996 189 199
26. A Fraser G Evan A license to kill Cell 85 1996 781 784
27. PA Henkart ICE family proteases: mediators of all apoptotic cell death? Immunity 4 1996 195 201
28. S Nagata Apoptosis by death factor Cell 88 1997 355 365
29. M Muzio AM Chinnaiyan FC Kischkel K O'Rourke A Shevchenko J Ni C Scaffidi JD Bretz M Zhang R Gentz M Mann PH Krammer ME Peter VM Dixit FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 1996 817 827
30. RMY Barge R Willemze P Vandenabeele W Fiers R Beyaert Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal FEBS Lett 409 1997 207 210
31. NL Harvey AJ Butt S Kumar Functional activation of Nedd2/ICH-1 (caspase-2) is an early process in apoptosis J Biol Chem 272 1997 13134 13139
32. NA Thornberry EP Peterson JJ Zhao AD Howard PR Griffin KT Chapman Inactivation of interleukin-1β converting enzyme by peptide (acyloxy)methyl ketones Biochemistry 33 1994 3934 3940
33. T Patel GJ Gores SH Kaufmann The role of proteases during apoptosis FASEB J 10 1996 587 597
34. MJL Eliasson K Sampei AS Mandir PD Hurn RJ Traystman J Bao A Pieper Z-Q Wang TM Dawson SH Snyder VL Dawson Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia Nat Med 3 1997 1089 1095
35. L Rao D Perez E White Lamin proteolysis facilitates nuclear events during apoptosis J Cell Biol 135 1996 1441 1455
36. C Brancolini D Lazarevic J Rodriguez C Schneider Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of β-catenin J Cell Biol 139 1997 759 771
37. C Caulín GS Salvesen RG Oshima Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis J Cell Biol 138 1997 1379 1394
38. L Chen V Marechal J Moreau AJ Levine J Chen Proteolytic cleavage of the mdm2 oncoprotein during apoptosis J Biol Chem 272 1997 22966 22973
39. X Tan SJ Martin DR Green JYJ Wang Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death J Biol Chem 272 1997 9613 9616
40. M Enari H Sakahira H Yokoyama K Okawa A Iwamatsu S Nagata A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD Nature 391 1998 43 50
41. DM Hockenbery Bcl-2 in cancer, development and apoptosis J Cell Sci 18 Suppl 1994 51 55
42. JC Reed Bcl-2 and the regulation of programmed cell death J Cell Biol 124 1994 1 6
43. G Kroemer The proto-oncogene bcl-2 and its role in regulating apoptosis Nat Med 3 1997 614 620
44. L function upstream of the ced-3-like apoptotic proteases J Biol Chem 271 1996 4573 4576
45. ZN Oltvai CL Milliman SJ Korsmeyer Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death Cell 74 1993 609 619
46. X-M Yin ZN Oltvai SJ Korsmeyer BH1, and BH2 domains of bcl-2, are required for inhibition of apoptosis, and heterodimerization with bax Nature 369 1994 321 323
47. S Ottilie J-L Diaz J Chang G Wilson KM Tuffo S Weeks M McConnell Y Wang T Oltersdorf LC Fritz Structural and functional complementation of an inactive bcl-2 mutant by bax truncation J Biol Chem 272 1997 16955 16961
48. Q-L Lu P Abel CS Foster E-N Lalani Bcl-2: role in epithelial differentiation and oncogenesis Hum Pathol 27 1996 102 110
49. T Kinoshita T Yokota K-i Arai A Miyajima Regulation of bcl-2 expression by oncogenic ras protein in hematopoietic cells Oncogene 10 1995 2207 2212
50. Y Leverrier J Thomas GR Perkins M Mangeney MKL Collins J Marvel In bone marrow derived baf-3 cells, inhibition of apoptosis by IL-3 is mediated by two independent pathways Oncogene 14 1997 425 430
51. D Hockenbery G Nuñez C Milliman RD Schreiber SJ Korsmeyer Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 348 1990 334 336
52. T Hirsch P Marchetti SA Susin B Dallaporta N Zamzami I Marzo M Geuskens G Kroemer The apoptosis-necrosis paradox: apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death Oncogene 15 1997 1573 1581
53. L forms an ion channel in synthetic lipid membranes Nature 385 1997 353 357
54. J Yang X Liu K Bhalla CN Kim AM Ibrado J Cai T-I Peng DP Jones X Wang Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked Science 275 1997 1129 1132
55. RM Kluck E Bossy-Wetzel DR Green DD Newmeyer The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis Science 275 1997 1132 1136
56. L FEBS Lett 415 1997 29 32
57. EH-Y Cheng DG Kirsch RJ Clem R Ravi MB Kastan A Bedi K Ueno JM Hardwick Conversion of bcl-2 to a bax-like death effector by caspases Science 278 1997 1966 1968
58. Y Tsujimoto J Cossman E Jaffe CM Croce Involvement of the bcl-2 gene in human follicular lymphoma Science 228 1985 1440 1443
59. N Rampino H Yamamoto Y Ionov Y Li H Sawai JC Reed M Perucho Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype Science 275 1997 967 969
60. DP Lane p53, guardian of the genome Nature 358 1992 15 16
61. D Michalovitz O Halevy M Oren Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 Cell 62 1990 671 680
62. J Martinez I Georgoff J Martinez AJ Levine Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein Genes Dev 5 1991 151 159
63. WS El-Deiry T Tokino VE Velculescu BD Levy R Parsons JM Trent D Lin WE Mercer KW Kinzler B Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
64. JW Harper GR Adami N Wei K Keyomarsi SJ Elledge The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816
65. SI Reed E Bailly V Dulic L Hengst D Resnitzky J Slingerland G1 control in mammalian cells J Cell Sci 18 Suppl 1994 69 73
66. T Miyashita S Krajewski M Krajewska HG Wang HK Lin DA Liebermann B Hoffman JC Reed Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene 9 1994 1799 1805
67. E Yonish-Rouach D Resnitzky J Lotem L Sachs A Kimchi M Oren Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 Nature 352 1991 345 347
68. M Kastan On the TRAIL from p53 to apoptosis? Nat Genet 17 1997 130 131
69. GI Evan AH Wyllie CS Gilbert TD Littlewood H Land M Brooks CM Waters LZ Penn DC Hancock Induction of apoptosis in fibroblasts by c-myc protein Cell 69 1992 119 128
70. JC Trent II DJ McConkey SM Loughlin MT Harbison A Fernandez HN Ananthaswamy Ras signaling in tumor necrosis factor-induced apoptosis EMBO J 15 1996 4497 4505
71. A Kauffmann-Zeh P Rodriguez-Viciana E Ulrich C Gilbert P Coffer J Downward G Evan Suppression of c-myc-induced apoptosis by ras signalling through PI(3)K and PKB Nature 385 1997 544 548
72. RL Ward AV Todd F Santiago T O'Connor NJ Hawkins Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis Cancer 79 1997 1106 1113
73. Ras in Ras-induced apoptosis J Biol Chem 271 1996 2376 2379
74. Y Li M Chopp N Jiang ZG Zhang C Zaloga Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats Stroke 26 1995 1252 1257
75. M Leist B Single AF Castoldi S Kühnle P Nicotera Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis J Exp Med 185 1997 1481 1486
76. Y Gavrieli Y Sherman SA Ben-Sasson Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation J Cell Biol 119 1992 493 501
77. R Gold M Schmied G Rothe H Zischler H Breitschopf H Wekerle H Lassmann Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections J Histochem Cytochem 41 1993 1023 1030
78. JH Wijsman RR Jonker R Keijzer CJH van de Velde CJ Cornelisse JH van Dierendonck A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA J Histochem Cytochem 41 1993 7 12
79. B Ansari PJ Coates BD Greenstein PA Hall In situ end-labelling detects DNA strand breaks in apoptosis, and other physiological, and pathological states J Pathol 170 1993 1 8
80. A Negoescu P Lorimier F Labat-Moleur C Drouet C Robert C Guillermet C Brambilla E Brambilla In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations J Histochem Cytochem 44 1996 959 968
81. T Shinohara K Ohshima H Murayama M Kikuchi Y Yamashita T Shirakusa Apoptosis and proliferation in gastric carcinoma: the association with histological type Histopathology 29 1996 123 129
82. P Lipponen S Aaltomaa V-M Kosma K Syrjänen Apoptosis in breast cancer as related to histopathological characteristics and prognosis Eur J Cancer 30A 1994 2068 2073
83. HAM van de Schepop JS de Jong PJ van Diest JPA Baak Counting of apoptotic cells: a methodological study in invasive breast cancer J Clin Pathol Mol Pathol 49 1996 M214 M217
84. CS Potten What is an apoptotic index measuring? (a commentary) Br J Cancer 74 1996 1743 1748
85. M Hahne D Rimoldi M Schröter P Romero M Schreier LE French P Schneider T Bornand A Fontana D Lienard J-C Cerottini J Tschopp Melanoma cell expression of Fas(APO-1/CD95) ligand: implications for tumor immune escape Science 274 1996 1363 1366
86. J O'Connell GC O'Sullivan JK Collins F Shanahan The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand J Exp Med 184 1996 1075 1082
87. A Migheli P Cavalla S Marino D Schiffer A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks J Neuropathol Exp Neurol 53 1994 606 616
88. SD Mundle XZ Gao S Khan SA Gregory HD Preisler A Raza Two in situ labeling techniques reveal different patterns of DNA fragmentation during spontaneous apoptosis in vivo, and induced apoptosis in vitro Anticancer Res 15 1995 1895 1904
89. CK Petito B Roberts Effect of postmortem interval on in situ end-labeling of DNA oligonucleosomes J Neuropathol Exp Neurol 54 1995 761 765
90. H Sasano In situ end labeling, and its applications to the study of endocrine disease: How can we study programmed cell death in surgical pathology materials? Endocrinol Pathol 6 1995 87 89
91. B Grasl-Kraupp B Ruttkay-Nedecky H Koudelka K Bukowska W Bursch R Schulte-Hermann In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note Hepatology 21 1995 1465 1468
92. FD Davison M Groves F Scaravilli The effects of formalin fixation on the detection of apoptosis in human brain by in situ end-labelling of DNA Histochem J 27 1995 983 988
93. NJ Hawkins J Lees RL Ward Detection of apoptosis in colorectal carcinoma by light microscopy and in situ end labelling Anal Quant Cytol Histol 19 1997 227 232
94. Y Soini U Törmänen P Pääkkö Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumours Histopathology 32 1998 28 34
95. L Leoncidi MT Del Vecchio D Spina T Megha P Barbini E Sabattini S Pileri P Tosi R Kraft JA Laissue H Cottier Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern Int J Cancer 61 1995 826 831
96. SW Kiberu JH Pringle S Sobolewski P Murphy I Lauder Correlation between apoptosis, proliferation and bcl-2 expression in malignant non-Hodgkin's lymphoma J Clin Pathol Mol Pathol 49 1996 M268 M272
97. IAM Gisbertz HC Schouten FJ Bot J-W Arends Proliferation and apoptosis in primary gastric B-cell non-Hodgkin's lymphoma Histopathology 30 1997 152 159
98. Y Soini H Raunio P Pääkkö High grade malignant non-Hodgkin's lymphomas differ from low grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax, and p53 Tumor Biol 19 1998 176 185
99. D Schlaifer S Krajewski S Galoin F Rigal-Huguet G Laurent P Massip J Pris G Delsol JC Reed P Brousset Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection Am J Pathol 149 1996 177 185
100. K Hell J Lorenzen R Fischer M-L Hansmann Hodgkin cells accumulate mRNA for bcl-2 Lab Invest 73 1995 492 496
101. F Rigal-Huguet J Gopas I Prinsloo J Pris G Delsol JC Reed D Schlaifer P Brousset D Benharroch S Krajewski G Laurent F Meggetto Frequent expression of the cell death-inducing gene bax in Reed-Sternberg cells of Hodgkin's disease Blood 87 1996 2470 2475
102. H zur Hausen HS Schulte-Holthausen G Klein W Henle G Henle P Clifford L Santesson EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx Nature 228 1970 1056 1058
103. LM Weiss LA Movahed RA Warnke J Sklar Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease N Engl J Med 320 1989 502 506
104. AP Burke TS Yen KM Shekitka LH Sobin Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction Mod Pathol 3 1990 377 380
105. S Henderson M Rowe C Gregory D Croom-Carter F Wang R Longnecker E Kieff A Rickinson Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death Cell 65 1991 1107 1115
106. M Mustonen H Raunio P Pääkkö Y Soini The extent of apoptosis is inversely associated with bcl-2 expression in premalignant and malignant breast lesions Histopathology 31 1997 347 354
107. V Bhargava DL Kell M van de Rijn RA Warnke Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity Am J Pathol 145 1994 535 540
108. Y Huang S Ray JC Reed AM Ibrado C Tang A Nawabi K Bhalla Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells Breast Cancer Res Treat 42 1997 73 81
109. H Joensuu L Pylkkänen S Toikkanen Bcl-2 protein expression and long-term survival in breast cancer Am J Pathol 145 1994 1191 1198
110. P Hellemans PA van Dam J Weyler AT van Oosterom P Buytaert E Van Marck Prognostic value of bcl-2 expression in invasive breast cancer Br J Cancer 72 1995 354 360
111. MK Heatley Association between the apoptotic index and established prognostic parameters in endometrial adenocarcinoma Histopathology 27 1995 469 472
112. M Saegusa Y Kamata M Isono I Okayasu Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas J Pathol 180 1996 275 282
113. DC Chhieng JS Ross RA Ambros Bcl-2 expression and the development of endometrial carcinoma Mod Pathol 9 1996 402 406
114. GS Henderson KA Brown SL Perkins TM Abbott F Clayton Bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma Mod Pathol 9 1996 430 438
115. NL Sandford JW Searle JF Kerr Successive waves of apoptosis in the rat prostate after repeated withdrawal of testosterone stimulation Pathology 16 1984 406 410
116. N Kyprianou HF English JT Isaacs Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation Cancer Res 50 1990 3748 3753
117. TJ McDonnell P Troncoso SM Brisbay C Logothetis LWK Chung J-T Hsieh S-M Tu ML Campbell Expression of the protooncogene bcl -2 in the prostate and its association with emergence of androgen-independent prostate cancer Cancer Res 52 1992 6940 6944
118. M Colombel F Symmans S Gil KM O'Toole D Chopin M Benson CA Olsson S Korsmeyer R Buttyan Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers Am J Pathol 143 1993 390 400
119. P Koivisto T Visakorpi I Rantala J Isola Increased cell proliferation activity and decreased cell death are associated with the emergence of hormone-refractory recurrent prostate cancer J Pathol 183 1997 51 56
120. M Krajewska S Krajewski JI Epstein A Shabaik J Sauvageot K Song S Kitada JC Reed Immunohistochemical analysis of bcl-2, bax, bcl-X and mcl-1 expression in prostate cancers Am J Pathol 148 1996 1567 1576
121. M Aihara PT Scardino LD Truong TM Wheeler JR Goad G Yang TC Thompson The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate Cancer 75 1995 522 529
122. F Basolo L Pollina G Fontanini L Fiore F Pacini A Baldanzi Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression Br J Cancer 75 1997 537 541
123. H Sasano A Imatani S Shizawa T Suzuki H Nagura Cell proliferation and apoptosis in normal and pathologic human adrenal Mod Pathol 8 1995 11 17
124. GW Wolkersdörfer C Marx JW Brown WA Scherbaum SR Bornstein Evaluation of apoptotic parameters in normal and neoplastic human adrenal Endocr Res 22 1996 411 419
125. A Negoescu F Labat-Moleur G Defaye P Mezin C Drouet E Brambilla EM Chambaz JJ Feige Contribution of apoptosis to the phenotypic changes of adrenocortical cells in primary culture Mol Cell Endocrinol 110 1995 175 184
126. Y Koshida M Saegusa I Okayasu Apoptosis, cell proliferation, and expression of Bcl-2, and Bax in gastric carcinomas: immunohistochemical and clinicopathological study Br J Cancer 75 1997 367 373
127. GB Baretton J Diebold G Christoforis M Vogt C Müller K Dopfer K Schneiderbanger M Schmidt U Löhrs Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas: aspects of carcinogenesis and prognostic significance Cancer 77 1996 255 264
128. M Krajewska CM Fenoglio-Preiser S Krajewski K Song JS Macdonald JS Stemmerman JC Reed Immunohistochemical analysis of bcl-2 family proteins in adenocarcinomas of the stomach Am J Pathol 149 1996 1449 1457
129. Y Soini N Virkajärvi V-P Lehto P Pääkkö Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival Br J Cancer 73 1996 1025 1030
130. N Virkajärvi P Pääkkö Y Soini Association between p53 overexpression, cell proliferation, tumor necrosis and extent of apoptosis in operated pancreatic adenocarcinoma APMIS 105 1997 765 772
131. F Charlotte A L'Herminé N Martin Y Geleyn M Nollet P Gaulard ES Zafrani Immunohistochemical detection of bcl-2 protein in normal and pathological human liver Am J Pathol 144 1994 460 465
132. M Zhao N-X Zhang M Economou I Blaha JA Laissue A Zimmermann Immunohistochemical detection of bcl-2 protein in liver lesions: Bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia Histopathology 25 1994 237 245
133. A Skopelitou M Hadjiyannakis V Alexpoulou O Krikoni S Kamina N Agnantis Topographical immunohistochemical expression of bcl-2 protein in human liver lesions Anticancer Res 16 1996 975 978
134. U Törmänen A-K Eerola P Rainio K Vähäkangas Y Soini R Sormunen R Bloigu V-P Lehto P Pääkkö Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma Cancer Res 55 1995 5595 5602
135. R Komaki T Fujii P Perkins JY Ro PK Allen KA Mason CF Mountain L Milas Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer Int J Radiat Oncol Biol Phys 36 1996 601 605
136. AJ O'Neill MJ Staunton EF Gaffney Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma Histopathology 29 1996 45 50
137. G Stammler M Volm Apoptosis in non-small cell lung cancer as related to drug resistance and prognosis Apoptosis 1 1996 95 99
138. N Ikegaki M Katsumata J Minna Y Tsujimoto Expression of bcl-2 in small cell lung carcinoma cells Cancer Res 54 1994 6 8
139. S-X Jiang T Kameya Y Sato N Yanase H Yoshimura T Kodama Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation Am J Pathol 148 1996 837 846
140. A-K Eerola U Törmänen P Rainio R Sormunen R Bloigu K Vähäkangas V-P Lehto Y Soini P Pääkkö Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity J Pathol 181 1997 172 177
141. MJ Staunton EF Gaffney Tumor type is a determinant of susceptibility to apoptosis Am J Clin Pathol 103 1995 300 307
142. ED King J Matteson SC Jacobs N Kyprianou Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression J Urol 155 1996 316 320
143. H Shiina M Igawa S Urakami S Honda H Shirakawa T Ishibe Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder J Clin Pathol 49 1996 395 399
144. P Lipponen M Eskelinen K Syrjänen Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein bcl-2 and c-myc have no independent prognostic value in renal adenocarcinoma Br J Cancer 71 1995 863 867
145. M Furihata H Sonobe Y Ohtsuki M Yamashita M Morioka A Yamamoto N Terao M Kuwahara N Fujisaki Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia J Pathol 178 1996 133 139
146. E Patsouris P Davaki N Kapranos P Davaris K Papageorgiou A study of apoptosis in brain tumors by in situ end-labeling method Clin Neuropathol 15 1996 337 341
147. Y Soini P Pääkkö Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors Hum Pathol 27 1996 1221 1226
148. JR Goldblum TW Rice Bcl-2 protein expression in the Barrett's metaplasia-dysplasia-carcinoma sequence Mod Pathol 8 1995 866 869
149. MA Birchall CM Winterford DJ Allan BV Harmon Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study Oral Oncol Eur J Cancer 31B 1995 380 383
150. M Ishida Y Gomyo S Tatebe S Ohfuji H Ito Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling Virchows Arch 428 1996 229 235
151. CC Flohil PA Janssen FT Bosman Expression of bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon J Pathol 178 1996 393 397
152. GY Lauwers GV Scott J Hendricks Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia Cancer 73 1994 2900 2904
153. G McGill A Shimamura RC Bates RE Savage DE Fisher Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts J Cell Biol 138 1997 901 911
154. RC Bates LF Lincz GF Burns Involvement of integrins in cell survival Cancer Metastasis Rev 14 1995 191 203
155. E Arai I Katayama Role of apoptosis in spontaneous regression of peripheral T-cell lymphoma arising in skin or subcutis Hum Pathol 28 1997 472 477
156. D Thomaidou MC Mione JFR Cavanagh JG Parnavelas Apoptosis and its relation to the cell cycle in the developing cerebral cortex J Neurosci 17 1997 1075 1085
157. DM Bortner MP Rosenberg Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis Cell Growth Differ 6 1995 1579 1589
158. CY Gao PS Zelenka Induction of cyclin B and H1 kinase activity in apoptotic PC12 cells Exp Cell Res 219 1995 612 618
159. W Meikrantz R Schlegel Apoptosis and the cell cycle J Cell Biochem 58 1995 160 174
160. O Kranenburg AJ van der Eb A Zantema Cyclin D1 is an essential mediator of apoptotic neuronal cell death EMBO J 15 1996 46 54
161. Y Sofer-Levi D Resnitzky Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E Oncogene 13 1996 2431 2437
162. HA Kargi S Aktas Ö Sağol S Ermete O Akpinar A Akkoclu Apoptosis bcl-2 and p53 expression and their relation to tumour stage in non-small cell lung carcinomas (NSCLC) Cancer Lett 116 1997 185 189
163. EF Gaffney AJ O'Neill MJ Staunton In situ end-labelling, light microscopic assessment, and ultrastructure of apoptosis in lung carcinoma J Clin Pathol 48 1995 1017 1021
164. 2, and bax in neuroendocrine lung tumors Am J Pathol 149 1996 1941 1952
165. S Tatebe M Ishida N Kasagi S Tsujitani N Kaibara H Ito Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: analysis by terminal-deoxynucleotidyl-transferase mediated dUTP-biotin nick end labeling Int J Cancer 65 1996 173 177
166. S Tsujitani H Shirai S Tatebe K Sugamura S Ohfuji Y Gomyo M Maeta H Ito N Kaibara Apoptotic cell death and its relationship to carcinogenesis in colorectal carcinoma Cancer 77 1996 1711 1716
167. NEI Langlois J Lamb O Eremin SD Heys Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products J Pathol 182 1997 392 397
168. G Yang TM Wheeler MW Kattan PT Scardino TC Thompson Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index Cancer 78 1996 1267 1271
169. S-X Jiang Y Sato S Kuwao T Kameya Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas J Pathol 177 1995 135 138
170. F Pezzella H Turley I Kuzu MF Tungekar MS Dunnill CB Pierce A Harris KC Gatter DY Mason Bcl-2 protein in non-small-cell lung carcinoma N Engl J Med 329 1993 690 694
171. FA Sinicrope DB Evans SD Leach KR Cleary CJ Fenoglio JJ Lee JL Abbruzzese bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome Clin Cancer Res 2 1996 2015 2022